Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to ...

The University of Rochester Medical Center (URMC) has resumed all surgeries, including elective procedures, following delays ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Baxter International Inc.’s Marion plant is now producing a limited amount of IV solutions, the manufacturer said Thursday. Baxter has restarted production on the line that produces the largest ...

The IV fluids response group advises that fluids remain in short supply, particularly 1L saline bags. There is some improved ...

Otsuka Holdings Co (JP:4578) has released an update. Otsuka Pharmaceutical Factory America, a subsidiary of Otsuka Pharmaceutical Factory, has ...